{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:13:55Z","timestamp":1793232835445,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503676"],"award-info":[{"award-number":["81503676"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2017A020213007"],"award-info":[{"award-number":["2017A020213007"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.phrs.2020.105101","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T22:09:48Z","timestamp":1596146988000},"page":"105101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines"],"prefix":"10.1016","volume":"160","author":[{"given":"Lei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaolong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenze","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.105101_bib0005","series-title":"Influenza (Seasonal)","author":"WHO","year":"2019"},{"key":"10.1016\/j.phrs.2020.105101_bib0010","series-title":"An Overview of Prevalence of Notifiable Diseases in China in 2018","author":"PRC NHCot","year":"2018"},{"key":"10.1016\/j.phrs.2020.105101_bib0015","series-title":"An Overview of Prevalence of Notifiable Diseases in China in January 2019","author":"PRC NHCot","year":"2019"},{"key":"10.1016\/j.phrs.2020.105101_bib0020","series-title":"Influenza Antiviral Medications: Summary for Clinicians","author":"Prevention CfDCa","year":"2019"},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jac\/dkr090","article-title":"Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life","volume":"66","author":"Kumar","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.phrs.2020.105101_bib0030","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.phrs.2020.105101_bib0035","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1136\/bmj.j2841","article-title":"WHO downgrades oseltamivir on drugs list after reviewing evidence","volume":"357","author":"Kmietowicz","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcma.2015.10.009","article-title":"Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): a meta-analysis","volume":"79","author":"Li","year":"2016","journal-title":"J. Chin. Med. Assoc."},{"issue":"43","key":"10.1016\/j.phrs.2020.105101_bib0045","first-page":"4100","article-title":"Analysis of the Use of Chinese Patent Medicine in 6 Grade \u2162-A Hospitals","volume":"22","author":"Wang","year":"2011","journal-title":"China Pharmacy"},{"key":"10.1016\/j.phrs.2020.105101_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-4505-11-1","article-title":"Editorial: can China master the guideline challenge?","volume":"11","author":"Yang","year":"2013","journal-title":"Health Res. Policy Syst."},{"issue":"12","key":"10.1016\/j.phrs.2020.105101_bib0055","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"63","author":"Brouwers","year":"2010","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105101_bib0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/M16-1565","article-title":"A reporting tool for practice guidelines in health care: the RIGHT statement","volume":"166","author":"Chen","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2020.105101_bib0065","series-title":"International Practice Guideline Registry Platform","author":"International Practice Guideline Registry Platform","year":"2019"},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0070","first-page":"524","article-title":"Who Should Participate in the Development of Clinical Practice Guidelines?","volume":"10","author":"Chen","year":"2019","journal-title":"Med. J. Peking Union Med. Coll. Hos."},{"key":"10.1016\/j.phrs.2020.105101_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2017.12.021","article-title":"Reporting of declarations and conflicts of interest in WHO guidelines can be further improved","volume":"98","author":"Wang","year":"2018","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2020.105101_bib0080","series-title":"Pharmacopoeia of the people\u2019s Republic of China","author":"Commission","year":"2015"},{"key":"10.1016\/j.phrs.2020.105101_bib0085","first-page":"359","article-title":"Evaluation of PICO as a knowledge representation for clinical questions","author":"Huang","year":"2006","journal-title":"AMIA Annual Symposium Proceedings AMIA Symposium"},{"issue":"9","key":"10.1016\/j.phrs.2020.105101_bib0090","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jclinepi.2014.04.003","article-title":"Network meta-analyses could be improved by searching more sources and by involving a librarian","volume":"67","author":"Li","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2020.105101_bib0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med. Res. Methodol."},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jclinepi.2014.12.009","article-title":"Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties","volume":"68","author":"Pieper","year":"2015","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2020.105101_bib0105","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2020.105101_bib0110","series-title":"The Newcastle-ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses","author":"Wells","year":"2019"},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"7652","key":"10.1016\/j.phrs.2020.105101_bib0120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2020.105101_bib0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jclinepi.2016.07.001","article-title":"The skills and experience of GRADE methodologists can be assessed with a simple tool","volume":"79","author":"Norris","year":"2016","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"7","key":"10.1016\/j.phrs.2020.105101_bib0135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2020.105101_bib0140","series-title":"Diagnosis and Treatment Programme of Influenza (2019)","author":"China NHCotPsRo","year":"2019"},{"issue":"30","key":"10.1016\/j.phrs.2020.105101_bib0145","first-page":"6","article-title":"Clinical observation of Lianhuaqingwen department of emergency, capsules in treatment of the influenza A\/H1N1","volume":"7","author":"Ouyang","year":"2010","journal-title":"China Med. Her."},{"issue":"10","key":"10.1016\/j.phrs.2020.105101_bib0150","first-page":"1351","article-title":"Analysis of effectiveness of Chinese medicine on influenza A (H1N1)","volume":"31","author":"Ma","year":"2010","journal-title":"Shanxi J. Trad. Chin. Med."},{"issue":"23","key":"10.1016\/j.phrs.2020.105101_bib0155","first-page":"91","article-title":"Clinical study of Lianhuaqingwen capsule in the treatment of influenza A (H1N1)","volume":"30","author":"Li","year":"2009","journal-title":"J. Med. Forum"},{"issue":"18","key":"10.1016\/j.phrs.2020.105101_bib0160","first-page":"2925","article-title":"Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial","volume":"124","author":"Duan","year":"2011","journal-title":"Chin. Med. J."},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0165","first-page":"38","article-title":"Clinical observation and nursing of relieving clinical symptom s of influenza H1N1with Lianhuaqingwen capsule","volume":"2","author":"Li","year":"2010","journal-title":"Chin. J. Chin. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105101_bib0170","first-page":"12","article-title":"A randomized controlled clinical study of Lianhuaqingwen capsule in the treatment of influenza A (H1N1)","volume":"29","author":"Liu","year":"2010","journal-title":"Chin. Comm. Doc."},{"issue":"05","key":"10.1016\/j.phrs.2020.105101_bib0175","first-page":"53","article-title":"Study on the pharmacological mechanism of Lianhuaqingwen capsule against influenza virus","volume":"12","author":"Wang","year":"2019","journal-title":"Chin. J. of Clin. Rational Drug Use"},{"issue":"10","key":"10.1016\/j.phrs.2020.105101_bib0180","first-page":"1265","article-title":"Observation on effectiveness of Lianhuaqingwen capsule on influenza","volume":"34","author":"Chen","year":"2018","journal-title":"J. Prac. Trad.l Chin.Med."},{"key":"10.1016\/j.phrs.2020.105101_bib0185","series-title":"Clinical Research Guidelines for New Drugs of Chinese Traditional Medicine on Influenza Treatment","author":"Administration","year":"2016"},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0190","first-page":"91","article-title":"Clinical study of Lianhuaqingwen capsule in the treatment of influenza A (H1N1)","volume":"14","author":"Zhang","year":"2016","journal-title":"J. China Pres. Drug"},{"issue":"27","key":"10.1016\/j.phrs.2020.105101_bib0195","first-page":"137","article-title":"Clinical effects of Lianhuaqingwen capsule combined with oseltamivir in the treatment of influenza","volume":"9","author":"Li","year":"2016","journal-title":"Chin. J.Clin.Rational Drug Use"},{"issue":"8","key":"10.1016\/j.phrs.2020.105101_bib0200","first-page":"666","article-title":"Clinical effects of Lianhuaqingwen Capsule on influenza virus","volume":"36","author":"Chen","year":"2017","journal-title":"Guansu Med. J."},{"issue":"15","key":"10.1016\/j.phrs.2020.105101_bib0205","article-title":"Analysis of the effects of oseltamivir combined with Lianhuaqingwen granule in the treatment of influenza A virus","volume":"7","author":"Du","year":"2019","journal-title":"Cardio. Dis.Elec. J. Inte. Trad. Chin. West.Med."},{"issue":"48","key":"10.1016\/j.phrs.2020.105101_bib0210","first-page":"145","article-title":"Clinical effects of Lianhuaqingwen capsule combined with oseltamivir in the treatment of influenza","volume":"6","author":"Qian","year":"2019","journal-title":"Elec. J. Clin. Med.Lite."},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0215","first-page":"290","article-title":"Phase \u2161 clinical study of Lianhuaqingwen capsule for influenza","volume":"16","author":"Yang","year":"2005","journal-title":"Trad. Chin.Drug Res. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2020.105101_bib0220","first-page":"517","article-title":"Clinical observation of 35 cases of Lianhuaqingwen capsule treated early stage of influenza","volume":"18","author":"Luo","year":"2011","journal-title":"Chin.J. Trad. Med. Sci.Technol."},{"issue":"28","key":"10.1016\/j.phrs.2020.105101_bib0225","first-page":"6840","article-title":"Observation on the effectiveness of Lianhuaqingwen capsule on influenza","volume":"11","author":"Zhou","year":"2011","journal-title":"Chin. J. Misdia."},{"issue":"2","key":"10.1016\/j.phrs.2020.105101_bib0230","first-page":"278","article-title":"Clinical effects of Lianhuaqingwen Capsule on influenza","volume":"25","author":"Chen","year":"2014","journal-title":"Mod. Diag. Treat."},{"issue":"27","key":"10.1016\/j.phrs.2020.105101_bib0235","first-page":"2146","article-title":"Lianhuaqingwen capsules for influenza :observation of clinical efficacy","volume":"19","author":"Wang","year":"2008","journal-title":"China Pharmacy"},{"issue":"6","key":"10.1016\/j.phrs.2020.105101_bib0240","first-page":"46","article-title":"Clinical observation on the treatment of influenza with Lianhuaqingwen capsule","volume":"48","author":"Jin","year":"2016","journal-title":"J. New Chin. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0245","first-page":"333","article-title":"Lianhuaqingwen capsule in the treatment of 100 cases of influenza","volume":"46","author":"Cui","year":"2011","journal-title":"Zhejiang J. Trad. Chin. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.105101_bib0250","first-page":"276","article-title":"Observation on effectiveness of Lianhuaqingwen capsule on 280 cases of influenza","volume":"4","author":"Yang","year":"2005","journal-title":"Chin. J. Diffi. Compli. Cases"},{"issue":"26","key":"10.1016\/j.phrs.2020.105101_bib0255","first-page":"157","article-title":"Phase \u2161 clinical study of Lianhuaqingwen capsule in the treatment of influenza","volume":"1","author":"Wang","year":"2016","journal-title":"Chin. J. Health Care Nut."},{"issue":"12","key":"10.1016\/j.phrs.2020.105101_bib0260","first-page":"29","article-title":"Lianhuaqingwen capsule in the treatment of 43 cases of influenza","volume":"12","author":"Wang","year":"2014","journal-title":"Chin. Med. Mod. Dis. Edu. China"},{"issue":"22","key":"10.1016\/j.phrs.2020.105101_bib0265","first-page":"105","article-title":"Phase \u2161 clinical study of Lianhuaqingwen capsule in the treatment of 43 cases of influenza","volume":"23","author":"Gao","year":"2014","journal-title":"China Pharma."},{"issue":"10","key":"10.1016\/j.phrs.2020.105101_bib0270","first-page":"1121","article-title":"Observation on the effects of Lianhuaqingwen granule on the prevention and treatment of influenza","volume":"24","author":"Yu","year":"2015","journal-title":"Mod. J. Integ. Trad. Chin.Western Med."},{"key":"10.1016\/j.phrs.2020.105101_bib0275","first-page":"250","article-title":"Clinical effect of Lianhuaqingwen Capsule on influenza","volume":"13","author":"Hou","year":"2018","journal-title":"Special Health"},{"issue":"11","key":"10.1016\/j.phrs.2020.105101_bib0280","article-title":"Analysis of effectiveness of Lianhuaqingwen capsule on influenza","author":"Liu","year":"2018","journal-title":"Med. Diet. Heal"},{"issue":"11","key":"10.1016\/j.phrs.2020.105101_bib0285","first-page":"2016","article-title":"Observation on the symptom outcome of Lianhuaqingwen capsule in the treatment of influenza","volume":"14","author":"Zhou","year":"2019","journal-title":"J. Psychol."},{"issue":"Z1","key":"10.1016\/j.phrs.2020.105101_bib0290","first-page":"141","article-title":"Effects of Lianhuaqingwen capsule in treatment of influenza","author":"Zhang","year":"2018","journal-title":"Doctor"},{"key":"10.1016\/j.phrs.2020.105101_bib0295","first-page":"259","article-title":"Analysis on the experience of Lianhuaqingwen capsule in the treatment of influenza","volume":"15","author":"Wang","year":"2018","journal-title":"Health Awar."},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0300","first-page":"102","article-title":"Clinical study on Chaishi antipyretic granule in the treatment of influenza","volume":"34","author":"Hu","year":"2018","journal-title":"Chin. Comm. Doc."},{"key":"10.1016\/j.phrs.2020.105101_bib0305","first-page":"343","article-title":"Clinical study of influenza","volume":"3","author":"Xiao","year":"2019","journal-title":"Charming China"},{"issue":"01","key":"10.1016\/j.phrs.2020.105101_bib0310","first-page":"43","article-title":"60 cases of influenza treated by syndrome differentiation","volume":"31","author":"Chen","year":"2019","journal-title":"J. Jiangxi Uni. TCM"},{"issue":"7","key":"10.1016\/j.phrs.2020.105101_bib0315","first-page":"981","article-title":"An open-label, multi-center, random-control clinical study of Xiangju capsules in treatment of influenza","volume":"14","author":"Du","year":"2019","journal-title":"China Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0320","first-page":"62","article-title":"Efficacy of Lianhuaqingwen capsule on influenza","volume":"13","author":"Qing","year":"2017","journal-title":"Healthc. Foodserv. Mag."},{"issue":"10","key":"10.1016\/j.phrs.2020.105101_bib0325","first-page":"120","article-title":"Clinical effects of Lianhuaqingwen capsule on influenza","volume":"23","author":"Liao","year":"2017","journal-title":"Contemporary Medicine"},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0330","first-page":"590","article-title":"Clinical effects of Lianhuaqingwen capsule on influenza","volume":"31","author":"Zou","year":"2015","journal-title":"J. Mod. Med. Health"},{"issue":"08","key":"10.1016\/j.phrs.2020.105101_bib0335","first-page":"90","article-title":"Clinical observation on Lianhua Qingwen capsule in the treatment of influenza","volume":"33","author":"Huang","year":"2017","journal-title":"Chin. Comm. Doc."},{"issue":"12","key":"10.1016\/j.phrs.2020.105101_bib0340","first-page":"1631","article-title":"Treating influenza patients of wind-heat affecting lung syndrome by Jinhuaqinggan granule: a double-blinded randomized control trial","volume":"33","author":"Li","year":"2013","journal-title":"Chin.J. Integ. Trad.West.Med."},{"issue":"12","key":"10.1016\/j.phrs.2020.105101_bib0345","first-page":"1664","article-title":"Clinical efficacy of different doses of Jinhuaqinggan granule on influenza and serum levels of cytokines","volume":"44","author":"Qi","year":"2016","journal-title":"Mod. Med. J."},{"key":"10.1016\/j.phrs.2020.105101_bib0350","first-page":"228","article-title":"Phase \u2162 clinical study, double-blinded, randomized control, Jinhuaqinggan granule for influenza with wind-heat affecting lung syndrome","author":"Li","year":"2013","journal-title":"Proceedings of 2013 Academic Annual Meeting of Chinese Association of Chinese Medicine; 2013"},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0355","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7326\/0003-4819-155-4-201108160-00005","article-title":"Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial","volume":"155","author":"Wang","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"05","key":"10.1016\/j.phrs.2020.105101_bib0360","first-page":"402","article-title":"Comparison of antipyretic effects of Ganmaotuire Yin and Jinhuaqinggan granules in treating influenza","volume":"56","author":"Meng","year":"2015","journal-title":"J. Tradit. Chin. Med."},{"issue":"06","key":"10.1016\/j.phrs.2020.105101_bib0365","first-page":"465","article-title":"Efficacy of treatment of influenza A (H1N1) with oseltamivir phosphate and isatis root granules","volume":"24","author":"Tu","year":"2013","journal-title":"Med. J. Chin. People\u2019s Armed Police Forces"},{"key":"10.1016\/j.phrs.2020.105101_bib0370","first-page":"136","article-title":"Analysis of the clinical effects of Bingduqing oral liquid on influenza","volume":"06","author":"Li","year":"2014","journal-title":"World Health Dig."},{"issue":"01","key":"10.1016\/j.phrs.2020.105101_bib0375","first-page":"25","article-title":"Clinical analysis of 100 cases of influenza treated with ribavirin injection","volume":"27","author":"Jiang","year":"2008","journal-title":"China Foreign Med. Treat."},{"issue":"25","key":"10.1016\/j.phrs.2020.105101_bib0380","first-page":"2839","article-title":"Efficacy of oseltamivir in the treatment of influenza A (H1N1)","volume":"13","author":"Jiang","year":"2010","journal-title":"Chin. Gen. Prac."},{"issue":"01","key":"10.1016\/j.phrs.2020.105101_bib0385","first-page":"14","article-title":"Economic evaluation of Shufengjiedu capsules versus oseltamivir capsules for adult patients with influenza-like illness","volume":"26","author":"Li","year":"2017","journal-title":"Chin. J. New Dr"},{"issue":"03","key":"10.1016\/j.phrs.2020.105101_bib0390","first-page":"263","article-title":"Clinical observation of Shufengjiedu capsule in the treatment of 100 cases of seasonal influenza in Beijing","volume":"38","author":"Niu","year":"2019","journal-title":"Beijing J. Trad. Chin. Med."},{"issue":"10","key":"10.1016\/j.phrs.2020.105101_bib0395","first-page":"1734","article-title":"Clinical study of Shufengjiedu capsule in the treatment of influenza","volume":"27","author":"Li","year":"2018","journal-title":"J.Emer. Chin. Med."},{"issue":"01","key":"10.1016\/j.phrs.2020.105101_bib0400","first-page":"67","article-title":"8 cases of influenza A H1N1 treated with Jingfangbaidu powder","volume":"28","author":"Dou","year":"2011","journal-title":"Infor.Trad. Chin.Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105101_bib0405","first-page":"692","article-title":"Analysis of 15 cases of severe influenza A (H1N1) treated by oseltamivir combined with Lianhuaqingwen capsule","volume":"31","author":"Sun","year":"2014","journal-title":"J. Guangxi Med. Uni."},{"key":"10.1016\/j.phrs.2020.105101_bib0410","series-title":"Update: New Guidance on Clinical Management of Influenza Infections","author":"WHO","year":"2018"},{"issue":"6","key":"10.1016\/j.phrs.2020.105101_bib0415","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2020.105101_bib0420","article-title":"Economic evaluation of ShufengJiedu capsules versus oseltamivir phosphate capsules for adult patients with influenza-like illness","volume":"26","author":"Li","year":"2017","journal-title":"Chin. J. New Drugs"},{"key":"10.1016\/j.phrs.2020.105101_bib0425","first-page":"22","article-title":"Pharmacoeconomics analysis of four treatment regimens for influenza","author":"Kuang","year":"2019","journal-title":"Chin. J. of Clin. Rational Drug Use"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:41:22Z","timestamp":1778794882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820314092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":85,"alternative-id":["S1043661820314092"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105101","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105101"}}